ARTICLE | Company News
Kymab, Sosei deal
May 2, 2016 7:00 AM UTC
Kymab and Sosei’s Heptares Therapeutics Ltd. subsidiary partnered to discover, develop and commercialize antibodies against multiple GPCRs for cancer indications. Heptares will use its StaR plaform t...